1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
JVM Co., Ltd.

JVM Co., Ltd.

KKRX:054950
22,100.00
KRW
+100.00
(+0.45%)
2,444.76EPS
9.59P/E
270.10BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6,464.37
7,060.8
7,148.8
8,038.93
8,778.49
8,593.4
9,428.25
5,001.52
10,054.96
12,326.69
13,635.35
13,840.61
15,028.53
15,257.85
Basic EPS, GAAP
1,190.5
809
421.5
909
947.5
676.5
496.48
452.5
777
1,368
2,278
2,504
2,461
2,444.76
Free Cash Flow per Basic Share
1,362.55
929.67
506.58
539.72
501.29
1,070.67
1,040.52
461.83
1,819.81
873.32
2,312.43
1,932.28
2,214.6
2,732.89
Dividend per Share
- -
- -
- -
102.14
50.29
150.43
177.96
101.2
199.98
200
299.94
399.95
499.91
- -
Book Value per Share
7,196.51
7,917.22
8,547.15
9,220.26
10,016.29
10,367.39
10,586.29
11,925.29
12,457.93
13,728.24
15,583.67
17,566.99
20,311.51
20,308.05
Tangible Book Value per Share
6,247.54
6,392.86
6,979.18
7,685.84
8,816.94
9,469.25
9,995.3
11,512.91
12,059.44
13,461.66
15,360.35
17,333.94
19,905.82
19,792.42
Basic Weighted Avg Shares
13
12
12
12
12
12
12
23
12
12
12
12
12
12
Sales/Revenue/Turnover
81,605
88,207
88,459
98,149
106,176
103,635
110,145
115,411
115,826
141,978
157,085
159,434
173,129
175,794
Operating Margin (%)
22.29
13.66
7.31
15.07
17.65
12.9
9.53
13.61
10.79
15.49
18.95
19.24
19.22
19.17
Depreciation Expense
3,908
4,574
6,059
6,599
6,290
6,813
7,030
5,673
5,595
4,942
4,905
4,768
4,913
5,208
Net Income, GAAP
15,029
10,106
5,216
11,098
11,460
8,159
5,800
10,442
8,951
15,756
26,244
28,844
28,351
28,167
Effective Tax Rate (%)
8.54
4.47
22.85
8.37
22.37
24.51
30.7
17.26
4.82
25.95
20.73
16.86
21.64
22.96
Profit Margin (%)
18.42
11.46
5.9
11.31
10.79
7.87
5.27
9.05
7.73
11.1
16.71
18.09
16.38
16.02
Working Capital
11,235
10,409
7,153
13,545
20,706
25,970
27,260
26,533
35,546
49,180
72,963
97,252
128,444
128,967
LT Debt
- -
2,766
2,111
1,964
- -
- -
345
415
543
814
660
639
1,145
1,054
Total Equity
90,120
98,832
104,900
112,167
121,143
123,167
123,609
137,355
143,490
158,121
179,492
202,336
233,947
233,907
Return on Invested Capital (%)
11.5
7.95
3.49
9.27
9.7
6.87
5.05
8.51
7.16
8.98
11.61
11.32
10.28
10.28
Return on Capital (%)
11.42
7.75
3.97
7.92
7.92
5.68
4.1
6.89
5.49
8.94
13.62
13.52
11.61
11.31
Return on Common Equity (%)
17.81
10.7
5.12
10.23
9.82
6.68
4.7
8
6.37
10.45
15.55
15.11
13
12.86

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
31,625
32,119
32,421
LT Borrowings
- -
- -
- -
LT Finance Leases
687
1,145
1,054
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
354,178
297,739
270,096

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
198,315
206,193
213,128
Cash, Cash Equivalents & STI
130,538
134,672
140,682
Accounts Receivable, Net
28,238
31,284
30,258
Inventories
33,295
34,571
34,258
Total Current Liabilities
73,245
77,749
84,161
Payables & Accruals
- -
- -
- -
ST Debt
31,625
32,119
32,421
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.46%
11.31%
15.62%
Free Cash Flow
29.96%
41.54%
14.62%
Net Income, GAAP
27.49%
27.3%
-1.71%
Sales/Revenue/Turnover
7.15%
8.73%
8.59%
Total Cash Common Dividend
- -
- -
25%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
40,160
37,746
37,371
44,158
159,434
2025
42,819
47,537
39,705
43,067
173,129
2026
45,484
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
717
525
599
663.73
2,504
2025
675
772.69
555.59
457.95
2,461
2026
658.47
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
399.95
2025
- -
- -
- -
- -
499.91
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sang-Wook Kim
Full Time Employees
322
Sector
Health technology
Industry
Medical specialties
Address
Daegu South Korea
IPO Date
Jun 7, 2006
Website
myjvm.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
JVM Co., Ltd. is a South Korea-based medical technology company that specializes in the development, manufacturing, and distribution of automated pharmacy and hospital medication management systems. Founded in 1977 and headquartered in Daegu, South Korea, the company operates as a subsidiary of Hanmi Science Co., Ltd. JVM provides automated hardware and software solutions designed to optimize prescription dispensing, packaging, inspection, and inventory control for retail pharmacies, hospital wards, long-term care facilities, and high-volume centralized dispensing hubs across South Korea, North America, Europe, and the Asia-Pacific region. The company's core product portfolio encompasses automated tablet dispensing and packaging systems, including the flagship ATDPS series (NSP, NS, and DO models) for sorting, counting, pouch-packaging, and printing oral solid medications; the next-generation MENITH robotic automated packaging system, which features articulated collaborative robotic arms and dual-canister exchange automation for high-speed pouch packaging; the INTIpharm automated medication dispensing cabinet (ADC) system, which provides secure point-of-care medication storage, tracking, and dispensing in clinical hospital settings; the VIZEN and VIZEN EX automated optical inspection systems, which utilize high-resolution imaging and vision analysis to verify pouch contents, pill shapes, and quantities; the WIZER automated pouch winding and cutting system; specialized peripheral hardware, including Pico automatic tablet counters, eztok PTP deblistering machines, and automated tablet crushers; proprietary consumables, including thermal transfer ribbons, specialized packaging paper, and medication canisters; and the OnCube integrated software suite, which coordinates pharmacy workflow management, inventory tracking, and enterprise connectivity with hospital and pharmacy information systems. In recent developments, JVM has expanded its international footprint through the global rollout of its MENITH robotic dispensing platform, securing major equipment supply contracts with large-scale industrial pharmacy operators in Europe, including Brocacef in the Netherlands; garnered the iF Design Award 2024 for the innovative architecture of its MENITH automation system; and broadened its commercial distribution channels across North America and Europe via JVM Europe B.V. to address growing global demand for high-throughput pharmacy automation and workforce optimization solutions.